The effects of long-term noninvasive ventilation in hypercapnic COPD patients: a randomized controlled pilot study

L De Backer, W Vos, B Dieriks, D Daems, S Verhulst, S Vinchurkar, K Ides, J De Backer, P Germonpre, W De Backer, L De Backer, W Vos, B Dieriks, D Daems, S Verhulst, S Vinchurkar, K Ides, J De Backer, P Germonpre, W De Backer

Abstract

Introduction: Noninvasive ventilation (NIV) is a well-established treatment for acute-on- chronic respiratory failure in hypercapnic COPD patients. Less is known about the effects of a long-term treatment with NIV in hypercapnic COPD patients and about the factors that may predict response in terms of improved oxygenation and lowered CO(2) retention.

Methods: In this study, we randomized 15 patients to a routine pharmacological treatment (n = 5, age 66 [standard deviation ± 6] years, FEV(1) 30.5 [±5.1] %pred, PaO(2) 65 [±6] mmHg, PaCO(2) 52.4 [±6.0] mmHg) or to a routine treatment and NIV (using the Synchrony BiPAP device [Respironics, Inc, Murrsville, PA]) (n = 10, age 65 [±7] years, FEV(1) 29.5 [±9.0] %pred, PaO(2) 59 [±13] mmHg, PaCO(2) 55.4 [±7.7] mmHg) for 6 months. We looked at arterial blood gasses, lung function parameters and performed a low-dose computed tomography of the thorax, which was later used for segmentation (providing lobe and airway volumes, iVlobe and iVaw) and post-processing with computer methods (providing airway resistance, iRaw) giving overall a functional image of the separate airways and lobes.

Results: In both groups there was a nonsignificant change in FEV(1) (NIV group 29.5 [9.0] to 38.5 [14.6] %pred, control group 30.5 [5.1] to 36.8 [8.7] mmHg). PaCO(2) dropped significantly only in the NIV group (NIV: 55.4 [7.7] → 44.5 [4.70], P = 0.0076; control: 52.4 [6.0] → 47.6 [8.2], NS). Patients actively treated with NIV developed a more inhomogeneous redistribution of mass flow than control patients. Subsequent analysis indicated that in NIV-treated patients that improve their blood gases, mass flow was also redistributed towards areas with higher vessel density and less emphysema, indicating that flow was redistributed towards areas with better perfusion. There was a highly significant correlation between the % increase in mass flow towards lobes with a blood vessel density of >9% and the increase in PaO(2). Improved ventilation-perfusion match and recruitment of previously occluded small airways can explain the improvement in blood gases.

Conclusion: We can conclude that in hypercapnic COPD patients treated with long-term NIV over 6 months, a mass flow redistribution occurs, providing a better ventilation-perfusion match and hence better blood gases and lung function. Control patients improve homogeneously in iVaw and iRaw, without improvement in gas exchange since there is no improved ventilation/perfusion ratio or increased alveolar ventilation. These differences in response can be detected through functional imaging, which gives a more detailed report on regional lung volumes and resistances than classical lung function tests do. Possibly only patients with localized small airway disease are good candidates for long-term NIV treatment. To confirm this and to see if better arterial blood gases also lead to better health related quality of life and longer survival, we have to study a larger population.

Keywords: COPD; imaging; noninvasive ventilation.

Figures

Figure 1
Figure 1
Functional imaging derived from a high resolution computed tomography scan.
Figure 2
Figure 2
Mass flow (re)distribution (left) and change in airway resistance per lobe (right) in a patient treated with noninvasive ventilation for 6 months. Abbreviations: RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
Figure 3
Figure 3
Mass flow (re)distribution (left graph) and change in airway resistance per lobe (right graph) in a patient not treated with noninvasive ventilation for 6 months. Abbreviations: RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
Figure 4
Figure 4
Changes in PaO2 (mmHg) in COPD patients treated with noninvasive ventilation for 6 months. Abbreviations: SE, standard error; SD, standard deviation.
Figure 5
Figure 5
Changes in PaO2 (mmHg) in COPD patients treated without noninvasive ventilation (controls). Abbreviations: SE, standard error; SD, standard deviation; NS, not significant.
Figure 6
Figure 6
Internal mass flow redistribution was bigger in noninvasive ventilation (NIV)- treated patients than in controls. Notes: Imaging showed higher internal mass flow redistribution in NIV-treated patients: better V/Q matching due to airflow redistribution in NIV-treated patients.
Figure 7
Figure 7
Correlation between redistribution of mass flow towards well-perfused lung zones (>9% blood flow) and PaO2 in COPD patients treated for 6 months with noninvasive ventilation. Notes: r = 0.95, P < 0.05 (Spearman Rank). Abbreviation: MF, mass flow.

References

    1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet. 2004;364(9434):613–620.
    1. Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J. 2002;20(3):529–538.
    1. Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD – a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203–223.
    1. Calverley PM. Closing the NETT on lung volume reduction surgery. Thorax. 2003;58(8):651–653.
    1. Rasche K, Hader C, Leidag M, Duchna HW, Orth M. Non-invasive ventilation in chronic obstructive pulmonary disease. J Physiol Pharmacol. 2004;55(Suppl 3):115–119.
    1. Plant PK, Elliott MW. Chronic obstructive pulmonary disease * 9: management of ventilatory failure in COPD. Thorax. 2003;58(6):537–542.
    1. Chu CM, Chan VL, Lin AW, Wong IW, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax. 2004;59(12):1020–1025.
    1. Tuggey JM, Plant PK, Elliott MW. Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis. Thorax. 2003;58(10):867–871.
    1. Quinnell TG, Pilsworth S, Shneerson JM, Smith IE. Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation. Chest. 2006;129(1):133–139.
    1. Simonds AK. Home ventilation. Eur Respir J Suppl. 2003;47:38s–46s.
    1. Simonds AK. Long-term ventilation in obstructive ventilatory disorders. Respir Care Clin N Am. 2002;8(4):533–544.
    1. Funk GC, Breyer MK, Burghuber OC, et al. Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure. Respir Med. 2011;105(3):427–434.
    1. Budweiser S, Hitzl AP, Jorres RA, et al. Impact of noninvasive home ventilation on long-term survival in chronic hypercapnic COPD: a prospective observational study. Int J Clin Pract. 2007;61(9):1516–1522.
    1. De Backer JW, Vos WG, Vinchurkar SC, et al. Validation of computational fluid dynamics in CT-based airway models with SPECT/CT. Radiology. 2010;257(3):854–862.
    1. De Backer JW, Vos WG, Burnell P, et al. Study of the variability in upper and lower airway morphology in Sprague-Dawley rats using modern micro-CT scan-based segmentation techniques. Anat Rec (Hoboken) 2009;292(5):720–727.
    1. De Backer JW, Vos WG, Gorle CD, et al. Flow analyses in the lower airways: patient-specific model and boundary conditions. Med Eng Phys. 2008;30(7):872–879.
    1. De Backer JW, Vos WG, Devolder A, et al. Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation. J Biomech. 2008;41(1):106–113.
    1. De Backer JW, Vanderveken OM, Vos WG, et al. Functional imaging using computational fluid dynamics to predict treatment success of mandibular advancement devices in sleep-disordered breathing. J Biomech. 2007;40(16):3708–3714.
    1. Van HC, De BJ, Vos W, et al. Anatomical and functional changes in the upper airways of sleep apnea patients due to mandibular repositioning: a large scale study. J Biomech. 2011;44(3):442–449.
    1. Vos W, De BJ, Devolder A, et al. Correlation between severity of sleep apnea and upper airway morphology based on advanced anatomical and functional imaging. J Biomech. 2007;40(10):2207–2213.
    1. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J. 2005;25(6):1025–1031.
    1. Windisch W, Haenel M, Storre JH, Dreher M. High-intensity noninvasive positive pressure ventilation for stable hypercapnic COPD. Int J Med Sci. 2009;6(2):72–76.
    1. Wijkstra PJ, Lacasse Y, Guyatt GH, et al. A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients with stable COPD. Chest. 2003;124(1):337–343.
    1. Netter FH. The Ciba Collection of Medical Illustrations, Vol 7: Respiratory System. Summit, NJ: CIBA; 1979.
    1. De Backer JW, Vos WG, Gorle CD, et al. Flow analyses in the lower airways: patient-specific model and boundary conditions. Med Eng Phys. 2008;30(7):872–879.
    1. Elliott MW. Domiciliary non-invasive ventilation in stable COPD? Thorax. 2009;64(7):553–556.
    1. McEvoy RD, Pierce RJ, Hillman D, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009;64(7):561–566.
    1. Borghi-Silva A, Mendes RG, Toledo AC, et al. Adjuncts to physical training of patients with severe COPD: oxygen or noninvasive ventilation? Respir Care. 2010;55(7):885–894.
    1. Wijkstra PJ, Wempe JB, van der Bij W, Klinkenberg T, ten Hacken NH, Koeter GH. Improved exercise tolerance can be achieved in chronic obstructive pulmonary disease (COPD) by means of non-pharmacological treatment. Ned Tijdschr Geneeskd. 2006;150(22):1213–1217. Dutch.
    1. Diaz O, Begin P, Andresen M, et al. Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD. Eur Respir J. 2005;26(6):1016–1023.
    1. Clini EM, Magni G, Crisafulli E, Viaggi S, Ambrosino N. Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: comparison of costs. Respiration. 2009;77(1):44–50.
    1. Tsolaki V, Pastaka C, Kostikas K, et al. Noninvasive ventilation in chronic respiratory failure: effects on quality of life. Respiration. 2010
    1. Duiverman ML, Wempe JB, Bladder G, et al. Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax. 2008;63(12):1052–1057.
    1. Casanova C, Celli BR, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest. 2000;118(6):1582–1590.
    1. Rossi AG. Inflammation. IDrugs; 2003-Sixth World Congress. Focus on chronic obstructive pulmonary disease; August 2–6, 2003; Vancouver, Canada. 2003. pp. 838–840.
    1. Krachman SL, Criner GJ. Sleep and long-term ventilation. Respir Care Clin N Am. 2002;8(4):611–629.
    1. Hill NS. Noninvasive ventilation for chronic obstructive pulmonary disease. Respir Care. 2004;49(1):72–87.
    1. Nickol AH, Hart N, Hopkinson NS, et al. Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV. Int J Chron Obstruct Pulmon Dis. 2008;3(3):453–462.
    1. Diaz O, Begin P, Torrealba B, Jover E, Lisboa C. Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J. 2002;20(6):1490–1498.
    1. Dreher M, Storre JH, Schmoor C, Windisch W. High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax. 2010;65(4):303–308.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel